Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 2
2002 7
2003 8
2004 11
2005 4
2006 14
2007 8
2008 7
2009 19
2010 23
2011 21
2012 23
2013 44
2014 41
2015 36
2016 38
2017 63
2018 86
2019 106
2020 133
2021 141
2022 144
2023 136
2024 43

Text availability

Article attribute

Article type

Publication date

Search Results

988 results

Results by year

Filters applied: . Clear all
Page 1
Global burden of disease: acute-on-chronic liver failure, a systematic review and meta-analysis.
Mezzano G, Juanola A, Cardenas A, Mezey E, Hamilton JP, Pose E, Graupera I, Ginès P, Solà E, Hernaez R. Mezzano G, et al. Gut. 2022 Jan;71(1):148-155. doi: 10.1136/gutjnl-2020-322161. Epub 2021 Jan 12. Gut. 2022. PMID: 33436495
BACKGROUND AND AIMS: Acute-on-chronic liver failure (ACLF) is characterised by acute decompensation of cirrhosis associated with organ failures. We systematically evaluated the geographical variations of ACLF across the world in terms of prevalence, mortality, aetio …
BACKGROUND AND AIMS: Acute-on-chronic liver failure (ACLF) is characterised by acute decompensation of cirrhosis associated wi …
N-acetylcysteine in non-acetaminophen-induced acute liver failure: a systematic review and meta-analysis of prospective studies.
Amjad W, Thuluvath P, Mansoor M, Dutta A, Ali F, Qureshi W. Amjad W, et al. Prz Gastroenterol. 2022;17(1):9-16. doi: 10.5114/pg.2021.107797. Epub 2021 Jul 14. Prz Gastroenterol. 2022. PMID: 35371352 Free PMC article. Review.
INTRODUCTION: There are discordant reports on N-acetylcysteine (NAC) efficacy in non-acetaminophen acute liver failure (ALF). AIM: To determine whether NAC is beneficial in non-acetaminophen ALF. ...The NAC treatment was associated with shorter hospital stay (standa …
INTRODUCTION: There are discordant reports on N-acetylcysteine (NAC) efficacy in non-acetaminophen acute liver failure (ALF). …
Plasma exchange in patients with acute and acute-on-chronic liver failure: A systematic review.
Tan EX, Wang MX, Pang J, Lee GH. Tan EX, et al. World J Gastroenterol. 2020 Jan 14;26(2):219-245. doi: 10.3748/wjg.v26.i2.219. World J Gastroenterol. 2020. PMID: 31988586 Free PMC article.
BACKGROUND: Acute liver failure (ALF) and acute-on-chronic liver (ACLF) carry high short-term mortality rate, and may result from a wide variety of causes. ...AIM: To assess utility of plasma exchange in liver failure and its effect on mortality …
BACKGROUND: Acute liver failure (ALF) and acute-on-chronic liver (ACLF) carry high short-term mortality rate, and may r …
Plasma exchange for acute and acute-on-chronic liver failure: A systematic review and meta-analysis.
Beran A, Mohamed MFH, Shaear M, Nayfeh T, Mhanna M, Srour O, Nawras M, Mentrose JA, Assaly R, Kubal CA, Ghabril MS, Hernaez R, Patidar KR. Beran A, et al. Liver Transpl. 2024 Feb 1;30(2):127-141. doi: 10.1097/LVT.0000000000000231. Epub 2023 Aug 3. Liver Transpl. 2024. PMID: 37530812
Plasma exchange (PE) is a promising therapeutic option in patients with acute liver failure (ALF) and acute-on-chronic liver failure (ACLF). However, the impact of PE on patient survival in these syndromes is unclear. ...PE may be considered in managin …
Plasma exchange (PE) is a promising therapeutic option in patients with acute liver failure (ALF) and acute-on-chronic live …
Safety and efficacy of regional citrate anticoagulation for continuous renal replacement therapy in liver failure patients: a systematic review and meta-analysis.
Zhang W, Bai M, Yu Y, Li L, Zhao L, Sun S, Chen X. Zhang W, et al. Crit Care. 2019 Jan 24;23(1):22. doi: 10.1186/s13054-019-2317-9. Crit Care. 2019. PMID: 30678706 Free PMC article.
However, some studies suggested that the use of citrate for CRRT in liver failure patients did not increase the risk of citrate-related complications. ...Closely monitoring the acid base status and electrolyte balance may be more necessary during RCA-CRRT in patient …
However, some studies suggested that the use of citrate for CRRT in liver failure patients did not increase the risk of citrat …
Child-Pugh Versus MELD Score for the Assessment of Prognosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis of Observational Studies.
Peng Y, Qi X, Guo X. Peng Y, et al. Medicine (Baltimore). 2016 Feb;95(8):e2877. doi: 10.1097/MD.0000000000002877. Medicine (Baltimore). 2016. PMID: 26937922 Free PMC article. Review.
Child-Pugh and MELD scores have been widely used for the assessment of prognosis in liver cirrhosis. A systematic review and meta-analysis aimed to compare the discriminative ability of Child-Pugh versus MELD score to assess the prognosis of cirrhotic patients.PubMed and E …
Child-Pugh and MELD scores have been widely used for the assessment of prognosis in liver cirrhosis. A systematic review and meta-ana …
Acute liver failure: A systematic review and network meta-analysis of optimal type of stem cells in animal models.
Ma JF, Gao JP, Shao ZW. Ma JF, et al. World J Stem Cells. 2023 Jan 26;15(1):1-15. doi: 10.4252/wjsc.v15.i1.1. World J Stem Cells. 2023. PMID: 36713788 Free PMC article.
BACKGROUND: The therapeutic effects of various stem cells in acute liver failure (ALF) have been demonstrated in preclinical studies. ...Further subgroup analysis and network meta-analysis showed that although mesenchymal stem cells are the current research hotspot, …
BACKGROUND: The therapeutic effects of various stem cells in acute liver failure (ALF) have been demonstrated in preclinical s …
Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review.
Gillessen A, Schmidt HH. Gillessen A, et al. Adv Ther. 2020 Apr;37(4):1279-1301. doi: 10.1007/s12325-020-01251-y. Epub 2020 Feb 17. Adv Ther. 2020. PMID: 32065376 Free PMC article.
These hepatoprotective effects were observed in clinical studies in patients with alcoholic or non-alcoholic fatty liver disease, including patients with cirrhosis. In a pooled analysis of trials in patients with cirrhosis, silymarin treatment was associated with a signifi …
These hepatoprotective effects were observed in clinical studies in patients with alcoholic or non-alcoholic fatty liver disease, inc …
Symptom prevalence and quality of life of patients with end-stage liver disease: A systematic review and meta-analysis.
Peng JK, Hepgul N, Higginson IJ, Gao W. Peng JK, et al. Palliat Med. 2019 Jan;33(1):24-36. doi: 10.1177/0269216318807051. Epub 2018 Oct 22. Palliat Med. 2019. PMID: 30345878 Free PMC article.
The health-related quality of life of patients with end-stage liver disease was significantly impaired when compared to healthy controls or patients with chronic liver disease. ...CONCLUSION: The symptom prevalence of patients with end-stage liver disease res …
The health-related quality of life of patients with end-stage liver disease was significantly impaired when compared to healthy contr …
Interventions for paracetamol (acetaminophen) overdose.
Chiew AL, Gluud C, Brok J, Buckley NA. Chiew AL, et al. Cochrane Database Syst Rev. 2018 Feb 23;2(2):CD003328. doi: 10.1002/14651858.CD003328.pub3. Cochrane Database Syst Rev. 2018. PMID: 29473717 Free PMC article. Review.
In high-income countries, paracetamol toxicity is a common cause of acute liver injury. There are various interventions to treat paracetamol poisoning, depending on the clinical status of the person. ...Acetylcysteine should be given to people at risk of toxicity including …
In high-income countries, paracetamol toxicity is a common cause of acute liver injury. There are various interventions to treat para …
988 results